一树药业品牌怎么样 申请店铺

我要投票 一树药业在中草药行业中的票数:40 更新时间:2024-12-27
一树药业是哪个国家的品牌?「一树药业」是 贵州一树连锁药业有限公司 旗下著名品牌。该品牌发源于贵州,由创始人王春雷在1999-03-11期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
一树药业怎么样

贵州一树连锁药业有限公司,成立于1999年4月,企业名称取自管仲名言“一树一获,谷也;一树十获,木也;一树百获,人也”,秉承十年树木,百年树人的“以人为本”的发展理念,公司自成立之日起,就严格按照“高起点、高标准”的要求,将国外零售企业的先进管理经验和OEC管理模式有机结合,建立了一套先进的质量保证体系和管理体系,是贵州省实力强的药品零售企业、A级纳税信用企业,名列中国药品零售连锁企业百强,被行业知名媒体评价为“中国药品零售行业的海尔”。

贵州一树连锁药业有限公司以“追求卓越,不断创新”为企业发展的核心理念,率先在深圳成立了中国药店贸易联盟,开辟了中国大的平价药品采购联盟;与此同时,贵州一树还走出西部,向东部发达地区的江苏省等多家国有企业输出管理,成为西部零售企业向东部企业输出管理的“人”。

贵州一树的出色表现,受到了全球药品零售巨头SUPER—PHARM集团的青睐,成功合资后成立了SUPER—PHARM(中国)有限公司,将欧美发达国家的先进药品零售概念引进中国,以化妆品和个人护理品为主导的药妆新体验,以普及专业的健康服务,倡导时尚的消费形式的SUPER—PHARM(中国)的零售业态从此引领着中国药品零售行业的潮流。合资后的贵州一树成为了中国医药零售行业家真正意义上的中外合资企业,为贵州一树从西部走向全国实现自己的梦想打下坚实的基础。

Guizhou Yishu chain Pharmaceutical Co., Ltd. was founded in April 1999. The company name is taken from Guan Zhong's famous saying "one tree, one harvest, one valley; one tree, ten harvest, wood; one tree, one hundred harvest, people". Adhering to the development concept of "people-oriented" of ten years of trees and one hundred years of people, the company, since its establishment, has strictly followed the requirements of "high starting point, high standard" to integrate foreign retail enterprises With the combination of advanced management experience and OEC management mode, it has established an advanced quality assurance system and management system. It is a powerful drug retail enterprise and A-level tax credit enterprise in Guizhou Province, ranking among the top 100 drug retail chain enterprises in China, and appraised as "Haier of China's drug retail industry" by the well-known media in the industry. Guizhou Yishu chain Pharmaceutical Co., Ltd. takes "pursuit of excellence and continuous innovation" as the core concept of enterprise development, and takes the lead in establishing China pharmacy trade alliance in Shenzhen, opening up China's large affordable drug purchase alliance; at the same time, Guizhou Yishu also goes out of the west, exports management to Jiangsu Province and other state-owned enterprises in the eastern developed areas, and becomes a Western retail enterprise to the East The "people" in the export management of enterprises. Guizhou Yishu's outstanding performance has been favored by the global pharmaceutical retail giant super Pharm group. After the successful joint venture, super Pharm (China) Co., Ltd. was established, which introduced the advanced pharmaceutical retail concepts from developed countries in Europe and the United States into China. With cosmetics and personal care products as the leading New experience of cosmetics, professional health services are popularized, and the fashionable consumption form of super is advocated - from then on, pharm's retail format has led the trend of China's pharmaceutical retail industry. After the joint venture, Guizhou Yishu has become a real Sino foreign joint venture of Chinese pharmaceutical retail industry, laying a solid foundation for Guizhou Yishu to realize its dream from the west to the whole country.

本文链接: https://brand.waitui.com/9522d1856.html 联系电话:139*****444 立即查看

千城特选小程序码

7×24h 快讯

沪深两市成交额连续第63个交易日突破1万亿

36氪获悉,沪深两市成交额连续第63个交易日突破1万亿,较上日此时放量近1100亿。

9分钟前

日本政府通过温室气体减排新目标:2035年度较2013年度减排60%

据报道,日本政府12月27日召开全球变暖对策推进总部(总部长:首相石破茂)会议,通过了全球变暖对策计划的修改方案,其中提出“2035年度较2013年度减排60%、2040年度减排73%”的温室气体减排新目标。日本政府将在征求公众意见后,在内阁会议上敲定修改方案,并力争在2025年2月底前向联合国汇报。(界面)

9分钟前

南京公用宣布并购,股价“提前”涨停,公司最新回应

26日晚间,南京公用公告,公司拟购买宇谷科技约68%股权并募集配套资金。本次交易预计不构成重大资产重组,不构成重组上市。公司股票自12月27日开市起停牌,预计不超过10个交易日。公告当日,该股录得涨停。对此,南京公用相关人士表示,公司主营能源业务,以传统燃气为主。同时也在布局新能源领域,包括充电桩业务等,不过体量尚小。目前相关事宜处于初步商谈阶段,后续情况以公司公告为准。关于股价“提前”涨停,前述人士表示,公司股价近期涨跌频繁,不清楚昨日涨停原因。交易双方不存在内幕消息泄露的情形。(21财经)

9分钟前

力箭一号遥六民营商业运载火箭飞行试验任务失利

12月27日9时3分,力箭一号遥六民营商业运载火箭在东风商业航天创新试验区点火升空,火箭飞行异常,飞行试验任务失利。具体原因正在进一步分析排查。(新华社)

9分钟前

韩国央行:超三成韩国人持有加密货币

韩国央行根据在Upbit、Bithumb、Coin One、Cobit和Gopax等五大韩国交易所拥有账户的投资者数量统计发布报告称,截至今年11月,在韩国交易所持有加密货币的人数超过1559万人,比10月份的1498万人增加了61万人。目前,韩国总人口预计在5123万人左右。这意味着,持有加密货币的人口数量相当于总人口的30%以上。报告称,韩国加密货币投资者的数量一直在上升,而在11月更是直线飙升。(财联社)

9分钟前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询